RTX001 (Resolution Therapeutics)

N/A

Report date: 2024/12/10 17:52:22

Base Information

Drug NameRTX001 (Resolution Therapeutics)
Drug Alias NameRTX001 (Resolution Therapeutics)RTX-001 (Resolution Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDecompensated Liver CirrhosisFibrosisPulmonary Fibrosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesResolution Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesResolution Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsDecompensated Liver CirrhosisFibrosisPulmonary Fibrosis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A